Economic Evaluation of Heart Failure Management in Colombian Clinics (EconoHeart)

This study has been completed.

Sponsor:

Information provided by:

AstraZeneca

ClinicalTrials.gov Identifier:

NCT01084564

First received: March 9, 2010

Last updated: NA

Last verified: March 2010

History: No changes posted

Purpose

Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.

Condition
Heart Failure Asthma


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Retrospective
Official Title:	Economic Evaluation of Heart Failure Management in Colombian Clinics

Resource links provided by NLM:

MedlinePlus related topics: Heart Failure

U.S. FDA Resources

Further study details as provided by AstraZeneca:

Primary Outcome Measures:

To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia [ Time Frame: 12 months ]
Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives


Enrollment:	300
Study Start Date:	January 2008
Study Completion Date:	June 2008
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)

Groups/Cohorts
1 moderate to severe uncontrolled asthma

Eligibility


Ages Eligible for Study:	18 Years to 65 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Moderate to severe uncontrolled asthma.

Criteria

Inclusion Criteria:

Asthma moderate to severe.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01084564

Sponsors and Collaborators

AstraZeneca

Investigators


Study Director:	Rodolfo Dennis, M.D.	Pontificia Universidad Javeriana
Principal Investigator:	MARÍA XIMENA ROJAS, M.D.	Pontificia Universidad Javeriana

More Information


Responsible Party:	MC MD, AstraZeneca
ClinicalTrials.gov Identifier:	NCT01084564 History of Changes
Other Study ID Numbers:	NIS-CCO-ATA-2007/1
Study First Received:	March 9, 2010
Last Updated:	March 9, 2010

Keywords provided by AstraZeneca:


Cost-effectiveness analysis Colombia

Additional relevant MeSH terms:


Heart Failure Heart Diseases Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 25, 2017

To Top